Supernus Pharmaceuticals Inc. (SUPN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Supernus Pharmaceuticals ...

    NASDAQ: SUPN · Real-Time Price · USD
    46.56
    -0.54 (-1.15%)
    At close: Sep 25, 2025, 10:15 AM

    Supernus Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 661.82M 607.52M 667.24M 579.77M
    Cost of Revenue
    		 77.91M 83.78M 87.22M 75.06M
    Gross Profit
    		 583.91M 523.74M 580.02M 504.71M
    Operating Income
    		 81.67M -5.27M 67.3M 86.03M
    Interest Income
    		 16.2M 10.45M 21.69M 10.57M
    Pretax Income
    		 97.87M 2.77M 60.74M 73.17M
    Net Income
    		 73.86M 1.32M 60.71M 53.42M
    Selling & General & Admin
    		 321.58M 336.36M 377.22M 304.76M
    Research & Development
    		 108.8M 91.59M 74.55M 90.47M
    Other Expenses
    		 71.87M 101.06M 82.63M 29.99M
    Operating Expenses
    		 502.25M 529.01M 534.4M 425.21M
    Interest Expense
    		 n/a 2.42M 7.07M 23.42M
    Selling & Marketing Expenses
    		 88.5M 99.7M 267.79M 199.71M
    Cost & Expenses
    		 580.15M 612.79M 621.62M 500.28M
    Income Tax Expense
    		 24M 1.45M 32K 19.75M
    Shares Outstanding (Basic)
    		 55.1M 54.54M 53.67M 53.1M
    Shares Outstanding (Diluted)
    		 55.96M 55.51M 61.68M 54.36M
    EPS (Basic)
    		 1.34 0.02 1.13 1.01
    EPS (Diluted)
    		 1.32 0.02 1.04 0.98
    EBITDA
    		 178.28M 90.04M 153.44M 129.19M
    EBIT
    		 97.87M 5.18M 67.81M 96.6M
    Depreciation & Amortization
    		 80.41M 84.86M 85.63M 32.59M

    Add to Watchlist